BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 5652520)

  • 1. Serum concentrations and renal clearances of amino acids of patients with chronic active hepatitis.
    Krawitt EL; Clifton JA
    Gastroenterology; 1968 May; 54(5):866-71. PubMed ID: 5652520
    [No Abstract]   [Full Text] [Related]  

  • 2. [Endogenous renal clearance of amino acids: variations in relation to age].
    Ghisolfi J; Augier D; Dalous A; Regnier C
    Arch Fr Pediatr; 1973 Feb; 30(2):131-43. PubMed ID: 4716964
    [No Abstract]   [Full Text] [Related]  

  • 3. Abnormal aminopyrine metabolism in patients with chronic hepatitis.
    Hepner GW; Piken E; Lechago J
    West J Med; 1981 May; 134(5):390-3. PubMed ID: 7257348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative studies on the effect of delayed therapy of chronic inflammatory liver diseases with prednisone or immunosuppressive agents].
    Evers C; Vorpahl WD; Weinreich J
    Med Welt; 1971 Mar; 12():465-8. PubMed ID: 5560083
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of chronic liver diseases with thioctic acid].
    Möller E; Brinkmann W; Weber O; Wildhirt E
    Med Klin; 1967 Mar; 62(10):380-4. PubMed ID: 4874626
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diagnosis and treatment of chronic hepatitis].
    Andreu Kern F; Carneado J; De la Santa J; Aguilar J; Loizaga JM
    Rev Esp Enferm Apar Dig; 1971 Mar; 33(6):675-86. PubMed ID: 5561661
    [No Abstract]   [Full Text] [Related]  

  • 7. [State of free amino acid metabolism in children with chronic liver diseases].
    Popov DT
    Vopr Okhr Materin Det; 1976 Sep; 21(9):44-5. PubMed ID: 997392
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of chronic active hepatitis (CAH): a retrospective review of 130 patients.
    Giusti G; Ruggiero G; Galanti B; Piccinino F; Russo M; Galante D; Sagnelli E; Utili R; Pasquale G; Nardiello S; Aloisio V
    Hepatogastroenterology; 1981 Oct; 28(5):245-9. PubMed ID: 7047337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognosis of chronic hepatitis].
    Terg R; Kogan Z; Abecasis R; Lorente S; Melazzini F; Podestá A
    Acta Gastroenterol Latinoam; 1980; 10(1):35-48. PubMed ID: 7435127
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunosuppressive treatment of chronic liver diseases in the clinical biochemical, immunological and histological evaluation of the liver].
    Boroń P; Szpakowicz T; Bobrowska E; Boroń-Kaczmarska A; Prokopowicz D; Borzuchowska A
    Z Gesamte Inn Med; 1981 May; 36(10):318-21. PubMed ID: 7303757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experiences with 6-mercaptopurine therapy in active chronic hepatopathies].
    Schimmelpfennig W; Schneider G; Theuer D; Wagner K; Zimmermann HB
    Dtsch Z Verdau Stoffwechselkr; 1969; 22():89-95. PubMed ID: 5380092
    [No Abstract]   [Full Text] [Related]  

  • 12. Prednisone for chronic active hepatitis: pharmacokinetics and serum binding in patients with chronic active hepatitis and steroid major side effects.
    Uribe M; Go VL; Kluge D
    J Clin Gastroenterol; 1984 Aug; 6(4):331-5. PubMed ID: 6481116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nature and prognostic significance of serial amino acid determinations in severe chronic active liver disease.
    McCullough AJ; Czaja AJ; Jones JD; Go VL
    Gastroenterology; 1981 Oct; 81(4):645-52. PubMed ID: 7262510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An unusual evolutive form of persistent chronic hepatitis].
    Wildhirt E
    Minerva Med; 1979 Oct; 70(47):3237-41. PubMed ID: 229435
    [No Abstract]   [Full Text] [Related]  

  • 15. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
    Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
    Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of therapy of active chronic hepatopathies with 6-mercaptopurine].
    Schneider G; Schimmelpfennig W; Theuer D; Wagner K; Zimmermann HB; Nack P
    Z Gesamte Inn Med; 1969 Apr; 24(8):Suppl:124-6. PubMed ID: 5802052
    [No Abstract]   [Full Text] [Related]  

  • 17. Caffeine clearance by two point analysis: a measure of liver function in chronic liver disease.
    Wittayalertpanya S; Israsena S; Thamaree S; Tongnopnoua P; Komolmit P
    Tokai J Exp Clin Med; 1996 Dec; 21(4-6):195-201. PubMed ID: 9300980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in renal excretion of amino acids in patients after portasystemic anastomoses].
    Nádvorníková H; Schück O; Vosmík J; Tomková D; Teplan V
    Vnitr Lek; 1985 Mar; 31(3):276-84. PubMed ID: 4036016
    [No Abstract]   [Full Text] [Related]  

  • 19. [Free amino acid spectrum in the serum in epidemic hepatitis].
    Triapyshko AD
    Vrach Delo; 1973 Jul; 7(7):137-40. PubMed ID: 4756036
    [No Abstract]   [Full Text] [Related]  

  • 20. [Tubular function in active chronic hepatitis. Description of its association with proximal tubular acidosis].
    García Puig J; Mateos Anton F; Martínez Gómez ME; Gil Aguado A; Barbado J; Arnalich F; Peña JM; Armalaz M; Vázquez JJ; Montero García A
    Rev Clin Esp; 1979 Aug 15-31; 154(3-4):107-12. PubMed ID: 523712
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.